BARCELONA—Accelerated radiotherapy with carbogen and nicotinamide (ARCON) significantly improved regional control while maintaining excellent speech and swallowing for a majority of patients with advanced laryngeal cancer in a phase-III randomized trial comparing it with accelerated radiotherapy alone. Study author Geert Janssens MD, from Radboud University Medical Centre, presented the data at the 3rd ESTRO Forum (April 24-28, 2015) and gave Oncology Times reporter Sarah Maxwell the details.
ARCON Improved Quality of Life in Advanced Laryngeal Cancer: Phase-III ARCON Trial
Further reading
Babies Use Object Permanence To Get What They Want 2022: A report from the journal: Pediatric Physical Therapy Regina Harbourne PhD, PT, PCS, FAPTA...
Mandeep Mehra talks about his report in the New England Journal of Medicine on the inflammatory effects of COVID-19 infection and the implications...
January 2020 Pediatric Physical Therapy journal highlights the importance of non-billable tasks that are essential to achieving good outcomes. The...
SOURCE: Pediatric Physical Therapy journal ARTICLE “Trends in Attitudes and Practice Patterns of Physical Therapists in Addressing Childhood...
Uptake of the Congenital Muscular Torticollis Guidelines Survey findings about the effectiveness of a recently-introduced clinical practice guideline...
BARCELONA—A new pencil beam scanning proton delivery technique—rescanning—could help limit the dose of radiation to surrounding tissues and organs by...